Technology

Biomatters was founded on the principle of creating software that can be used by all researchers in their daily work. Our technology converts raw data into meaningful, visual information, simplifying research and ultimately improving efficiency.

Biomatters’ flagship software packages are:

• Geneious — a platform that dramatically speeds up research times and improves collaboration with tools to quickly filter, store, process and analyze gene and protein data. Providing industry standard bioinformatics tools at the fingertips of all researchers in biology, therapeutics and genetics.
• Cheesecake — a software system that streamlines and simplifies experimental protocols, ethics reporting and data management for laboratories doing in vivo research.

Biomatters also provides professional scientific computing consultancy services to assist organization’s specific scientific research and data management needs
…more

News

Biomatters announce Geneious Server™ Private Beta

(3 Mar 2010)

Geneious Server™ is a completely new software package designed specifically for high intensity computational needs. It will be sold separately from Geneious Pro™ and is designed to run on a... MORE

A Letter from the CEO, Candace Toner

(20 Jan 2010)

Dear Geneious Customers, I would like you to be the first to know about four big events coming up in Geneious’ evolution. In the next few months, we will be... MORE

Biomatters to donate 5% of the value of purchased licenses in December to help rebuild in Samoa

(15 Dec 2009)

At 6:48:11 local time in Samoa on September 29, 2009, a sub-marine earthquake occurred that devastated parts of Samoa, American Samoa and Tonga. Biomatters is linked with the people of... MORE

Investors

Biotechnology - A ‘sunrise’ industry

Biotechnology is a growth industry, both in the traditional academic and commercial sense.  Biotech as an industry is a vital economic development focus for many governments around the world, and New Zealand is no exception.

New Zealand has a strong background in scientific innovation and discovery.  The current biotech industry offers world-class research to occur in a stable, cost-competitive and strategic part of the world.

“Within New Zealand, just over 50% of the venture dollars invested in 2007 were directed to the biotech industry giving biotech companies a much larger slice of the venture pie than is typical in the US or Europe”
(Source: Ernst & Young Global biotechnology Report 2008 – Beyond Borders)

... more